Skip to main content
eScholarship
Open Access Publications from the University of California

PRMT1-mediated methylation of the EGF receptor regulates signaling and cetuximab response

  • Author(s): Liao, HW
  • Hsu, JM
  • Xia, W
  • Wang, HL
  • Wang, YN
  • Chang, WC
  • Arold, ST
  • Chou, CK
  • Tsou, PH
  • Yamaguchi, H
  • Fang, YF
  • Lee, HJ
  • Lee, HH
  • Tai, SK
  • Yang, MH
  • Morelli, MP
  • Sen, M
  • Ladbury, JE
  • Chen, CH
  • Grandis, JR
  • Kopetz, S
  • Hung, MC
  • et al.

Published Web Location

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4665782/
No data is associated with this publication.
Abstract

Posttranslational modifications to the intracellular domain of the EGFR are known to regulate EGFR functions; however, modifications to the extracellular domain and their effects remain relatively unexplored. Here, we determined that methylation at R198 and R200 of the EGFR extracellular domain by protein arginine methyltransferase 1 (PRMT1) enhances binding to EGF and subsequent receptor dimerization and signaling activation. In a mouse orthotopic colorectal cancer xenograft model, expression of a methylation-defective EGFR reduced tumor growth. Moreover, increased EGFR methylation sustained signaling activation and cell proliferation in the presence of the therapeutic EGFR monoclonal antibody cetuximab. In colorectal cancer patients, EGFR methylation level also correlated with a higher recurrence rate after cetuximab treatment and reduced overall survival. Together, these data indicate that R198/R200 methylation of the EGFR plays an important role in regulating EGFR functionality and resistance to cetuximab treatment.

Many UC-authored scholarly publications are freely available on this site because of the UC Academic Senate's Open Access Policy. Let us know how this access is important for you.

Item not freely available? Link broken?
Report a problem accessing this item